Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
For eligible patients, Semaglutide GLP-1 injections offer a path toward better overall health, reduced weight, and a decreased risk of associated diseases, all while providing a well-tolerated and clinically proven treatment option
Consider these results from one study : After three months of taking semaglutide, people without type 2 diabetes lost 6.3% of their body weight , on average, compared with 3.9% for those with type 2 diabetes
Schedule a comprehensive metabolic consultation at Revivify Lean Clinic today
Inflammation during obesity is not all bad: evidence from animal and human studies
USA 102 , 761766
In women, obesity itself is a significant risk factor for infertility, contributing to anovulation, polycystic ovary syndrome (PCOS), and menstrual irregularities
